Nutraceutical Moringa oleifera extract improve gut microbiota of type 2 Diabetes mellitus individuals: gut microbiome model

Vol 2, 2022 - 154240
Pôster
Favorite this paper
How to cite this paper?
Abstract

Nutraceutical Moringa oleifera extract improve gut microbiota of type 2 Diabetes mellitus individuals: gut microbiome model
Sônia Mariza Luiz De Oliveira1 , Fernando Oda2, Mateus Kawata Salgaço2, Victoria Mesa3,4, Adilson Sartoratto5, André Gonzaga dos Santos2 Katia Sivieri1,2*
1 Anhanguera University, São Paulo, Brazil
2Department of Food and Nutrition, School of Pharmaceutical Science, São Paulo State University-UNESP, Araraquara, Brazil
3 Faculty of Pharmacy, Paris University, Paris, France
4 Food and Human Nutrition Research Group, University of Antioquia, Medellín, Colombia
5 CPQBA-UNICAMP, Brazil
Keywords:, SHIME®, polyphenol, dysbiosis
Abstract
The microbiota represents an ecosystem that remains relatively stable during adulthood, however, factors such as genetics, stage of life, early nutrition, drug exposure and dietary pattern can contribute to an imbalance of the intestinal microbiota, triggering several diseases, including diabetes mellitus (DM). Among the types of DM, type 2 diabetes mellitus (T2DM) is the most prevalent and represents about 90 to 95% of all cases of DM. Considered a metabolic disorder, T2DM is characterized by resistance to insulin action and the inability of the beta cell to maintain an adequate insulin secretion. There is evidence that the intestinal microbiota is a risk factor in the occurrence and development of diabetes. We aimed to show the effect of Moringa Oleifera Lamarck extract on the intestinal microbiota of individuals with T2DM individuals through the intestinal microbiome model. In this study, two treatments were used: Experiment 1: a single dose of Lyophilized Moringa Extract (LME) (300 mg) was applied once and incubated for 48 h to 37 °C (acute treatment). Then, from 1 week later, 100 mg/daily of LME were administered by adding to the SHIME feeding medium for 7 days (chronic treatment). Our results showed an increase in the Firmicutes/Bacteriodetes ratio, Ruminococcaceae family, Subdoligranulum, Faecalibacterium, and Blautia genus after 7 days of 100 mg of LME intake. A decreased of ammonium ion production was observed 48h and 7 days of LME treatment, however, no significant change was observed for SCFA production after LME treatment (48 h or 7 days). Finally, LME showed an excellent potential to be used soon as an adjuvant treatment for T2DM, however, future studies are needed to increase the understanding of the complex interaction between the gut microbiota and T2DM, and to allow the development of new effective therapies.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Estadual Paulista “Júlio de Mesquita Filho” - Campus Araraquara
  • 2 ANHANGUERA EDUCACIONAL
  • 3 University of Antioquia
  • 4 Universidade Estadual de Campinas
Track
  • Food and health (AS)
Keywords
SHIME®
polyphenol
dysbiosis